IMNM Insider Trading Activity and SEC Form 4 Filings
IMNM insider trading summary
Over the past 12 months, insiders at Immunome Inc. (IMNM) reported 24 sales worth $20.8M by 7 insiders and 11 open-market purchases worth $2.3M by 3 insiders on SEC Form 4. Net insider selling was $18.5M.
Latest IMNM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Jack Higgins | Chief Scientific Officer | Sell | $334K (13,200 @ $25.32) |
| Aug 12, 2026 | Isaac Barchas | Insider | Sell | $301K (11,048 @ $27.25) |
| Aug 11, 2026 | Isaac Barchas | Insider | Sell | $1.6M (62,291 @ $26.23) |
| Aug 10, 2026 | Isaac Barchas | Insider | Sell | $264K (10,125 @ $26.07) |
| Aug 7, 2026 | Isaac Barchas | Insider | Sell | $397K (15,248 @ $26.06) |
| Aug 6, 2026 | Isaac Barchas | Insider | Sell | $543K (20,840 @ $26.06) |
| Jul 7, 2026 | Isaac Barchas | Insider | Sell | $409K (16,906 @ $24.20) |
| Jul 7, 2026 | Kinney Horn | Chief Business Officer | Sell | $27K (1,092 @ $25.00) |
| Jul 6, 2026 | Isaac Barchas | Insider | Sell | $2.0M (83,094 @ $24.11) |
| Jul 2, 2026 | Robert Lechleider | Chief Medical Officer | Sell | $369K (16,214 @ $22.76) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.